• SENSEX 74,534.42
    383.38 (+0.52%)
  • BANKNIFTY 54,909.65
    642.25 (+1.18%)
  • Jio Platforms
    1,435.55 1,490.00(%)
  • NSE
    1,778.10 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,403.50(%)
  • Anand Rathi Wea.
    2,257.60 1,354.00(%)
  • Sagility
    41.79 35.82(%)
  • Ather Energy
    1,778.00 1,741.90(%)
  • Laurus Labs
    2,388.00 2,245.00(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Indian Hotels Co
    824.00 816.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • Hexaware Tech.
    499.25 400.35(%)
  • Godrej Consumer
    777.65 810.35(%)
  • Suzlon Energy
    33.21 36.30(%)
  • Diamond Power
    345.90 406.80(%)
  • Equitas Sma. Fin
    47.26 51.30(%)
  • APL Apollo Tubes
    2,166.05 1,691.05(%)
  • Global Health
    1,266.90 955.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sanofi India Ltd Pharmaceuticals - Multinational

  • MNC Asc-Hoechst
  • BSE Code : 256.0
  • ISIN : INE058A01010
3,189.50 198 (6.60%)
  • As on 30 Oct 2026 (EOD)

  • Today’s Low

    3,010.00

  • Today’s High

    3,209.00

  • Open

    3,010.00

  • Perv Close

    2,992.00

  • 52W Low

    2,758.20

  • 52W High

    4,898.00

Key Indicators

  • P/E(TTM)

    21.43

  • Mar.Cap (₹Cr.)

    7,345.42

  • Div & Yield %

    3.85

  • Book Value(₹)

    358.68

  • Debt-Equity Ratio

    6.60

  • AGM Date

    29-Oct-2026

  • EPS

    148.84

  • P/E Ratio

    21.43

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7,345.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.03

  • BV (₹)

    358.70

  • Sales( ₹ in Cr.)

    1,837.40

  • NP (in Cr.)

    346.38

  • NP Var(%)

    -22.0

  • Div%

    1230.0

  • CPS (₹)

    166.60

  • EPS (₹)

    150.40

  • Traded Value (₹ in Lakhs)

    7,345.76

  • 52 Week High

    4,898.00

  • 52 Week Low

    2,758.20

  • Price BSE

    3190.0

  • Price NSE

    3,190.00

  • Market Capital( in Cr.)

    7,345.76

  • P/C Ratio

    19.10

  • P/E Ratio

    21.20

  • Price Vs.BV

    150.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Dec 2024 Dec 2023 Dec 2022 Dec 2021 Dec 2020 Dec
INCOME :            
Sales Turnover 1,837.40 2,013.20 2,851.10 2,770.10 2,956.60 2,901.90
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,837.40 2,013.20 2,851.10 2,770.10 2,956.60 2,901.90
Other Income 19.70 116.30 83.10 203.50 563.60 89.80
Stock Adjustments -136.80 -60.20 292.40 11.10 -43.10 -57.50
Total Income 1,720.30 2,069.30 3,226.60 2,984.70 3,477.10 2,934.20
EXPENDITURE :            
Raw Materials 760.40 919.10 1,493.40 1,200.70 1,263.70 1,196.10
Power and Fuel Cost 14.60 11.60 14.60 14.30 13.90 23.60
Employee Cost 185.30 240.20 370.60 405.90 433.90 460.80
Other Manufacturing Expenses 22.10 34.20 75.30 74.30 73.70 90.30
Selling and Administration Expenses 186.50 212.10 332.60 315.70 306.90 306.80
Miscellaneous Expenses 67.70 82.70 53.00 65.90 58.90 95.40
Employee Benefit Expenses 185.30 240.20 370.60 405.90 433.90 460.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,236.60 1,499.90 2,339.50 2,076.80 2,151.00 2,173.00
Operating Profit 483.70 569.40 887.10 907.90 1,326.10 761.20
Interest 1.70 1.50 1.70 1.70 1.80 1.80
Gross Profit 482.00 567.90 885.40 906.20 1,324.30 759.40
Depreciation 37.30 36.70 39.60 41.90 66.70 82.20
Profit Before Tax 444.70 531.20 845.80 864.30 1,257.60 677.20
Current Tax 122.90 125.80 243.30 245.20 336.00 211.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.90 -8.10 -0.70 -1.50 -22.80 -11.40
Reported Net Profit 326.70 413.50 603.20 620.60 944.40 477.60
Extraordinary Items -19.68 -28.77 12.68 94.55 363.33 -30.63
Adjusted Net Profit 346.38 442.27 590.52 526.05 581.07 508.23
Adjustment below Net Profit 1.70 -185.00 -1.30 0.50 -3.30 -8.80
P & L Balance brought forward 445.80 601.90 843.20 1,795.10 1,694.60 2,029.60
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 442.20 384.60 843.20 1,573.00 840.60 803.80
P & L Balance carried down 332.00 445.80 601.90 843.20 1,795.10 1,694.60
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,230.00 1,170.00 1,670.00 5,700.00 4,900.00 3,650.00
Dividend Per Share(Rs) 123.00 117.00 167.00 570.00 490.00 365.00
Earnings Per Share-Unit Curr 142.04 179.78 262.26 269.83 410.61 207.65
Earnings Per Share(Adj)-Unit Curr 142.04 179.78 262.26 269.83 410.61 207.65
Book Value 325.74 374.17 441.52 554.70 967.65 921.30
Book Value(Adj)-Unit Curr 325.74 374.17 441.52 554.70 967.65 921.30

Shareholding Pattern

  • Promoter Group

    60.40%

  • Public Share Holding

    39.60%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 10,409,587 45.20 10,409,587 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 10,409,587 45.20 10,409,587 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,500,000 15.20 3,500,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,500,000 15.20 3,500,000 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 100 0.00 100 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 202 0.00 2 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 500 0.00 500 1
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,320,209 5.73 1,320,209 117
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,483,037 10.78 2,483,037 8
Mutual Funds / UTI 1,985,694 8.62 1,985,644 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,455 0.01 1,455 3
Trusts 94 0.00 94 2
Venture Capital Funds 0 0.00 0 0
Sub total 5,791,291 25.15 5,791,041 146
2] Non Institution
Bodies Corporate 187,951 0.82 187,650 435
Clearing Members 6,955 0.03 6,955 22
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 236,013 1.02 235,783 2,097
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 100,210 0.44 100,210 1,978
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 96,471 0.42 96,471 2
Individuals holding nominal share capital up to Rs. 1 lakh 2,648,852 11.50 2,590,500 75,382
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 65 0.00 65 2
Others 45,797 0.20 45,797 1
Sub Total 3,329,744 14.46 3,270,661 79,940
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,030,622 100.00 22,971,289 80,089

Company Background

Sanofi India LtdPharmaceuticals - Multinational

  • Sanofi India Ltd
  • BSE Code : 256.0
  • ISIN : INE058A01010

  • Incorporation Year

    1956

  • Registered Office

    Sanofi Hse 117-B Saki Vihar Rd
    L&T Business Park Powai, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-28032000

  • FAX

    91-22-28032939

  • Chairman

    Rahul Bhatnagar

  • Managing Director

    DEEPAK ARORA

  • Company Secretary

    HARESH BACHUBHAI VALA

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sanofi India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sanofi India 3,189.65 1,857.10 1,837.40 22.69 54.17
Abbott India 26,107.90 7,217.19 6,929.05 34.36 43.78
Astrazeneca Phar 6,298.05 2,304.07 2,275.58 92.82 27.86
Glaxosmi. Pharma 2,515.65 3,932.76 3,790.20 40.19 58.17
Novartis India 1,813.30 393.10 354.33 45.79 15.94
Cipla 1,357.00 20,102.60 18,979.95 41.36 13.88
Bliss GVS Pharma 682.50 773.53 729.81 63.43 12.51
Amrutanjan Healt 493.40 520.13 502.55 26.43 24.16
Fermenta Biotec. 439.75 474.15 450.25 20.53 18.77
Guj. Themis Bio. 374.85 168.25 165.82 100.23 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77